Astria Therapeutics, Inc. Common Stock
ATXS Real Time Price USDRecent trades of ATXS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ATXS's directors and management
Government lobbying spending instances
-
$40,000 Apr 21, 2025 Issue: Pharmacy
-
$40,000 Jan 21, 2025 Issue: None
-
$40,000 Oct 21, 2024 Issue: Pharmacy
-
$40,000 Jul 19, 2024 Issue: Pharmacy
-
$40,000 Apr 19, 2024 Issue: None
-
$40,000 Jan 22, 2024 Issue: Pharmacy
Estimated quarterly lobbying spending
ATXS Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ATXS
Recent picks made for ATXS stock on CNBC
ETFs with the largest estimated holdings in ATXS
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ATXS stock a Buy, Sell, or Hold?
- What is the price target for $ATXS stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ATXS stock?
- Who owns the most shares of $ATXS stock?
- What funds own $ATXS stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ATXS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.